Influence of body weight on perioperative complications of thoracoscopic lobectomy

doi:10.3760/cma.j.issn.1007-1245.2024.16.011

Abstract

Abstract:

Objective　To investigate the influence of body weight on perioperative complications of thoracoscopic lobectomy. Methods　A total of 190 patients who underwent thoracoscopic lobectomy in the Department of Thoracic Surgery, Anyang Tumor Hospital from January 2023 to May 2023 were retrospectively selected as the study objects. According to the Chinese body mass index (BMI) standard, the patients were divided into a normal weight group (18.5 kg/m²≤BMI<24.0 kg/m²) of 76 cases and a high weight group (BMI ≥24.0 kg/m²) of 114 cases. There were 41 males and 35 females in the normal weight group, the age was (61.0±8.7) years old, the BMI was (21.9±1.4) kg/m², the preoperative American Society of Anesthesiologists (ASA) classification was grade I in 6 cases and grade II in 70 cases, and the tumor size was (2.3±1.6) cm. There were 53 males and 61 females in the high weight group, the age was (61.9±9.3) years old, the BMI was (26.9±2.3) kg/m², the preoperative ASA classification was grade I in 13 cases and grade II in 101 cases, and the tumor size was (2.3±1.8) cm. The incidence of postoperative complications and clinical outcomes were compared between the two groups. χ² test and t test were used. Results　In this study, the operation time of enrolled patients was (155.2±50.8) min, and the operation time of the normal weight group [(157.5±51.4) min] was slightly longer than that of the high weight group [(153.6±50.6) min], with no statistically significant difference (P>0.05). There was no statistically significant difference in the incidence of intraoperative bleeding between the two groups (P>0.05). The length of hospital stay after surgery of enrolled patients in this study was (17.7±4.5) d, and there was no statistically significant difference in the length of hospital stay between the normal weight group [(17.6±4.9) d] and the high weight group [(17.8±4.3) d] (P>0.05). There was no statistically significant difference in the incidence of complications within 30 d after surgery between the normal weight group [44.7% (34/76)] and the high weight group [28.9% (33/114)] (P>0.05), and no death occurred within 30 d after surgery between the two groups. Conclusion　High body weight does not increase the incidence of perioperative complications in patients undergoing thoracoscopic lobectomy, and thoracoscopic lobectomy is safe and feasible for patients with high body weight.

Key words:

Body weight, Lobectomy, Perioperative period, Complications

摘要：

目的　探讨体重对胸腔镜下肺叶切除术围手术期并发症的影响。方法　回顾性选取2023年1月至2023年5月于安阳市肿瘤医院胸外科行胸腔镜下肺叶切除术的190例患者作为研究对象。根据中国体重指数（BMI）标准，将患者分为正常体重组（18.5 kg/m²≤BMI<24.0 kg/m²）76例与高体重组（BMI≥24.0 kg/m²）114例。正常体重组男41例，女35例；年龄（61.0±8.7）岁；BMI（21.9±1.4）kg/m²；术前美国麻醉医师协会（ASA）分级：Ⅰ级6例，Ⅱ级70例；肿瘤大小（2.3±1.6）cm。高体重组男53例，女61例；年龄（61.9±9.3）岁；BMI（26.9±2.3）kg/m²；术前ASA分级：Ⅰ级13例，Ⅱ级101例；肿瘤大小（2.3±1.8）cm。比较两组患者术后并发症的发生率及临床疗效。采用χ²检验和t检验。结果　本研究入组患者手术时间为（155.2±50.8）min，正常体重组手术时间［（157.5±51.4）min］略长于高体重组［（153.6±50.6）min］，差异无统计学意义（P>0.05）。两组患者术中出血发生率比较，差异无统计学意义（P>0.05）。本研究入组患者术后住院时间为（17.7±4.5）d，正常体重组术后住院时间［（17.6±4.9）d］与高体重组［（17.8±4.3）d］比较，差异无统计学意义（P>0.05）。正常体重组术后30 d内并发症发生率［44.7%（34/76）］与高体重组［28.9%（33/114）］比较，差异无统计学意义（P>0.05），两组患者均未发生术后30 d内死亡。结论　高体重不会增加胸腔镜下肺叶切除术患者围手术期并发症的发生率，高体重患者行胸腔镜下肺叶切除术是安全可行的。

关键词:

体重, 肺叶切除术, 围手术期, 并发症

Wei Xudong.

Influence of body weight on perioperative complications of thoracoscopic lobectomy [J]. International Medicine and Health Guidance News, 2024, 30(16): 2687-2690.

魏旭东.

体重对胸腔镜下肺叶切除术围手术期并发症的影响 [J]. 国际医药卫生导报, 2024, 30(16): 2687-2690.

References

[1] Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):E359-386. DOI: 10.1002/ijc.29210.
[2] 中华医学会肿瘤学分会,中华医学会杂志社.中华医学会肺癌临床诊疗指南(2022版)[J].中华肿瘤杂志,2022,44(6):457-490.DOI:10.3760/cma.j.cn112152-20220413-00255.
[3] 刘莹洁.肺癌患者肺叶切除术后并发症发生的危险因素[J].吉林医学,2022,43(12):3238-3240.DOI:10.3969/j.issn.1004-0412.2022.12.022.
[4] Bamgbade OA, Rutter TW, Nafiu OO, et al. Postoperative complications in obese and nonobese patients[J]. World J Surg, 2007, 31(3):556-560; discussion 561. DOI: 10.1007/s00268-006-0305-0.
[5] Tulinský L, Sengul I, Ihnát P, et al. Obesity in cases undergoing the surgical procedure of lung lobectomy: risk or benefit?[J]. Rev Assoc Med Bras (1992), 2022, 68(8):1090-1095. DOI: 10.1590/1806-9282.20220526.
[6] 李鹏飞,赖玉田,周坤,等.应用Clavien-Dindo分级系统对肺癌患者术后并发症分级及危险因素分析[J].中国肺癌杂志,2017,20(4):264-271.DOI:10.3779/j.issn.1009-3419. 2017.04.07.
[7] 赵红建,俎德玲,诸葛毅,等.代谢综合征体重指数与血脂参数的相关性分析[J].中国药业,2012,21(3):51-52.DOI:10.3969/j.issn.1006-4931.2012.03.030.
[8] Wang L, Liu W, He X, et al. Association of overweight and obesity with patient mortality after acute myocardial infarction: a meta-analysis of prospective studies[J]. Int J Obes (Lond), 2016, 40(2):220-228. DOI: 10.1038/ijo.2015.176.
[9] Vemmos K, Ntaios G, Spengos K, et al. Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox[J]. Stroke, 2011, 42(1):30-36. DOI: 10.1161/STROKEAHA.110.593434.
[10] Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox[J]. Thromb Res, 2011, 128(6):518-523. DOI: 10.1016/j.thromres.2011.10.019.
[11] Barba R, Zapatero A, Losa JE, et al. Body mass index and mortality in patients with acute venous thromboembolism: findings from the RIETE registry[J]. J Thromb Haemost, 2008, 6(4):595-600. DOI: 10.1111/j.1538-7836.2008.02907.x.
[12] Stamou SC, Nussbaum M, Stiegel RM, et al. Effect of body mass index on outcomes after cardiac surgery: is there an obesity paradox?[J]. Ann Thorac Surg, 2011, 91(1):42-47. DOI: 10.1016/j.athoracsur.2010.08.047.
[13] Antoniou SA, Antoniou GA, Koch OO, et al. Laparoscopic versus open obesity surgery: a meta-analysis of pulmonary complications[J]. Dig Surg, 2015,32(2):98-107. DOI: 10.1159/000371749.
[14] van Huisstede A, Biter LU, Luitwieler R, et al. Pulmonary function testing and complications of laparoscopic bariatric surgery[J]. Obes Surg, 2013, 23(10):1596-1603. DOI: 10.1007/s11695-013-0928-9. PMID: 23515977.
[15] Launer H, Nguyen DV, Cooke DT. National perioperative outcomes of pulmonary lobectomy for cancer in the obese patient: a propensity score matched analysis[J]. J Thorac Cardiovasc Surg, 2013, 145(5):1312-1318. DOI: 10.1016/j.jtcvs.2012.10.012.
[16] 王朋飞,代伟娜,刘礼新,等.高体质量指数对胸腔镜下肺癌根治术围术期并发症及临床疗效的影响[J].肿瘤研究与临床,2019,31(3):167-171.DOI:10.3760/cma.j.issn.1006-9801.2019.03.006.
[17] Tulinský L, Mitták M, Tomášková H, et al. Obesity paradox in patients undergoing lung lobectomy - myth or reality?[J]. BMC Surg, 2018, 18(1):61. DOI: 10.1186/s12893-018- 0395-2.
[18] 胡志鹏,高哲俊,杨林江,等.胸腔镜与开胸肺叶切除术的比较[J].中国微创外科杂志,2016,16(11):965-968.DOI:10.3969/j.issn.1009-6604.2016.11.002.
[19] 丁志丹,王跃斌,方泽民.全胸腔镜肺叶切除术治疗老年原发性肺癌的临床疗效[J].中华老年医学杂志,2019,38(4):419-422.DOI:10.3760/cma.j.issn.0254-9026.2019.04.017.
[20] 王芳,姚灵琪,曹敏芳.不同体重指数患者行全麻腹腔镜手术的生理变化[J].浙江创伤外科,2022,27(1):44-45.DOI:10.3969/j.issn.1009-7147.2022.01.019.
[21] 周耘,杨柳,纳学晴.肥胖与全麻诱导期氧储备的相关性[J].昆明医科大学学报,2020,41(11):150-153.DOI:10.12259/j.issn.2095-610X.S20201130.
[22] 李斌,王燕,陈苏君.非小细胞肺癌肺叶切除术后体重指数与临床预后的关系[J].中国医药科学,2020,10(16):188-190,198.DOI:10.3969/j.issn.2095-0616.2020.16.050.
[23] Li S, Wang Z, Huang J, et al. Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the 'obesity paradox' really exist?[J]. Eur J Cardiothorac Surg, 2017, 51(5):817-828. DOI: 10.1093/ejcts/ezw386.
[24] Nakagawa T, Toyazaki T, Chiba N, et al. Prognostic value of body mass index and change in body weight in postoperative outcomes of lung cancer surgery[J]. Interact Cardiovasc Thorac Surg, 2016, 23(4):560-566. DOI: 10.1093/icvts/ivw175.